Positives

• Patients usually discuss bebtelovimab in acute-COVID or persistent-virus conversations. One immunocompromised patient described using it with Paxlovid during acute infection and then still facing longer-term symptoms afterward. Reddit.

Negatives

• Bebtelovimab has not been authorized for emergency use since November 2022 because it does not neutralize Omicron subvariants BQ.1 and BQ.1.1, cutting off access for patients FDA.
• Lilly later requested full EUA revocation because all manufactured lots had expired and the company would not offer the product in the US again, ending the supply chain entirely Drugs.com.
• Patients given bebtelovimab early in the pandemic commonly report it reduced acute mortality versus standard of care but did not appear to improve their long-term symptom burden PMC.

Hurdles & Side Effects

• Some patients mostly ask whether monoclonal antibodies might help, so bebtelovimab is usually discussed as clinician-directed acute-COVID care rather than a routine Long COVID treatment. Reddit.